Synthesis and antiviral activity of three pyrazole analogues of distamycin A. 1994

L Ding, and L Grehn, and E De Clercq, and G Andrei, and R Snoeck, and J Balzarini, and B Fransson, and U Ragnarsson
Department of Biochemistry, Uppsala University, Sweden.

The synthesis of three new monopyrazole analogues of the antiviral compound distamycin A is reported. Suitably protected 4-amino-1-methylpyrrole-2-carboxylic acid and 3-amino-1-methylpyrazole-5-carboxylic acid derivatives were chosen as starting materials. The construction of the trimeric polyamide framework was accomplished by assembly of the monomeric precursors under condensing conditions by analogy with our previous methodology, although with significant improvements in some pivotal steps. After chromatographic purification and spectroscopic characterisation, the analogues were assayed for antiviral activity. Compounds 7a-c inhibited vaccinia virus at a concentration similar to or lower than distamycin A and the related antibiotic netropsin. Analogues 7b and 7c exhibited an antiviral effect comparable to those of distamycin A and netropsin against HSV-1 and HSV-2, whereas their antiviral activity against several other viruses including HIV-1 and HIV-2 was somewhat lower. The cellular toxicity of 7a-c toward different host cell types proved to be of similar magnitude or lower than those of distamycin A and netropsin.

UI MeSH Term Description Entries
D007202 Indicators and Reagents Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant & Hackh's Chemical Dictionary, 5th ed, p301, p499) Indicator,Reagent,Reagents,Indicators,Reagents and Indicators
D007364 Intercalating Agents Agents that are capable of inserting themselves between the successive bases in DNA, thus kinking, uncoiling or otherwise deforming it and therefore preventing its proper functioning. They are used in the study of DNA. Intercalating Agent,Intercalating Ligand,Intercalative Compound,Intercalator,Intercalators,Intercalating Ligands,Intercalative Compounds,Agent, Intercalating,Agents, Intercalating,Compound, Intercalative,Compounds, Intercalative,Ligand, Intercalating,Ligands, Intercalating
D009429 Netropsin A basic polypeptide isolated from Streptomyces netropsis. It is cytotoxic and its strong, specific binding to A-T areas of DNA is useful to genetics research. Sinanomycin,Congocidine,IA-887,Netropsin Hydrochloride,T-1384,Hydrochloride, Netropsin
D011720 Pyrazoles Azoles of two nitrogens at the 1,2 positions, next to each other, in contrast with IMIDAZOLES in which they are at the 1,3 positions.
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D004214 Distamycins Oligopeptide antibiotics from Streptomyces distallicus. Their binding to DNA inhibits synthesis of nucleic acids.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D014616 Vaccinia virus The type species of ORTHOPOXVIRUS, related to COWPOX VIRUS, but whose true origin is unknown. It has been used as a live vaccine against SMALLPOX. It is also used as a vector for inserting foreign DNA into animals. Rabbitpox virus is a subspecies of VACCINIA VIRUS. Buffalopox virus,Poxvirus officinale,Rabbitpox virus,Buffalo Pox Virus,Rabbit Pox Virus,Buffalo Pox Viruses,Buffalopox viruses,Rabbit Pox Viruses,Rabbitpox viruses,Vaccinia viruses,Virus, Buffalo Pox,Viruses, Buffalo Pox,virus, Buffalopox

Related Publications

L Ding, and L Grehn, and E De Clercq, and G Andrei, and R Snoeck, and J Balzarini, and B Fransson, and U Ragnarsson
February 1999, Bioorganic & medicinal chemistry,
L Ding, and L Grehn, and E De Clercq, and G Andrei, and R Snoeck, and J Balzarini, and B Fransson, and U Ragnarsson
November 1986, Anti-cancer drug design,
L Ding, and L Grehn, and E De Clercq, and G Andrei, and R Snoeck, and J Balzarini, and B Fransson, and U Ragnarsson
January 1965, Antimicrobial agents and chemotherapy,
L Ding, and L Grehn, and E De Clercq, and G Andrei, and R Snoeck, and J Balzarini, and B Fransson, and U Ragnarsson
April 2004, Journal of medicinal chemistry,
L Ding, and L Grehn, and E De Clercq, and G Andrei, and R Snoeck, and J Balzarini, and B Fransson, and U Ragnarsson
July 1983, Journal of medicinal chemistry,
L Ding, and L Grehn, and E De Clercq, and G Andrei, and R Snoeck, and J Balzarini, and B Fransson, and U Ragnarsson
January 2005, Journal of medicinal chemistry,
L Ding, and L Grehn, and E De Clercq, and G Andrei, and R Snoeck, and J Balzarini, and B Fransson, and U Ragnarsson
February 2010, Chemical & pharmaceutical bulletin,
L Ding, and L Grehn, and E De Clercq, and G Andrei, and R Snoeck, and J Balzarini, and B Fransson, and U Ragnarsson
September 2009, European journal of medicinal chemistry,
L Ding, and L Grehn, and E De Clercq, and G Andrei, and R Snoeck, and J Balzarini, and B Fransson, and U Ragnarsson
April 2011, Molecules (Basel, Switzerland),
L Ding, and L Grehn, and E De Clercq, and G Andrei, and R Snoeck, and J Balzarini, and B Fransson, and U Ragnarsson
January 1964, Chemotherapia,
Copied contents to your clipboard!